- Home
- WYY vs PYPD Comparison
WYY vs PYPD Comparison
Compare WYY & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYY
- PYPD
- Stock Information
- Founded
- WYY 1991
- PYPD 2008
- Country
- WYY United States
- PYPD Israel
- Employees
- WYY N/A
- PYPD N/A
- Industry
- WYY EDP Services
- PYPD Medical/Dental Instruments
- Sector
- WYY Technology
- PYPD Health Care
- Exchange
- WYY Nasdaq
- PYPD Nasdaq
- Market Cap
- WYY 29.5M
- PYPD 34.8M
- IPO Year
- WYY 1998
- PYPD 2020
- Fundamental
- Price
- WYY $5.22
- PYPD $3.45
- Analyst Decision
- WYY Strong Buy
- PYPD Strong Buy
- Analyst Count
- WYY 2
- PYPD 5
- Target Price
- WYY $7.50
- PYPD $12.00
- AVG Volume (30 Days)
- WYY 113.1K
- PYPD 63.7K
- Earning Date
- WYY 08-14-2025
- PYPD 08-13-2025
- Dividend Yield
- WYY N/A
- PYPD N/A
- EPS Growth
- WYY N/A
- PYPD N/A
- EPS
- WYY N/A
- PYPD N/A
- Revenue
- WYY $144,421,640.00
- PYPD N/A
- Revenue This Year
- WYY $9.19
- PYPD N/A
- Revenue Next Year
- WYY $10.81
- PYPD N/A
- P/E Ratio
- WYY N/A
- PYPD N/A
- Revenue Growth
- WYY 16.25
- PYPD N/A
- 52 Week Low
- WYY $2.19
- PYPD $2.30
- 52 Week High
- WYY $6.25
- PYPD $3.93
- Technical
- Relative Strength Index (RSI)
- WYY 75.13
- PYPD 52.95
- Support Level
- WYY $4.65
- PYPD $3.35
- Resistance Level
- WYY $5.07
- PYPD $3.52
- Average True Range (ATR)
- WYY 0.33
- PYPD 0.12
- MACD
- WYY 0.08
- PYPD 0.00
- Stochastic Oscillator
- WYY 93.75
- PYPD 59.82
About WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.